Evaluation of Herpes Zoster Vaccination in HIV-Infected Patients 50 Years of Age and Older

Abstract

Get full access to this article

View all access options for this article.

References

Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Diseases Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America, 2015. https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed December 29, 2015.

Rubin

Levin

Ljungman

. 2013 Infectious Disease Society of America clinical practice guidelines for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:e44-e100. doi:10.1093/cid/cit684.

Benson

Hua

Andersen

. ZOSTAVAX is generally safe and immunogenic in HIV+ adults virologically suppressed on ART: results of a phase 2, randomized, double-blind, placebo-controlled trial. Paper presented at: 19th Conference on Retroviruses and Opportunistic Infections; March 5-8, 2012; Seattle, WA.

Tasker

Schnepf

Lim

. Unintended smallpox vaccination in HIV-1-infected individuals in the United States military. Clin Infect Dis. 2004;38:1320-1322.

National Institute of Allergy and Infectious Diseases, Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events. http://rsc.tech-res.com/Document/safetyandpharmacovigilance/DAIDS_AE_GRADING_TABLE_v2_NOV2014.pdf. Accessed October 10, 2014.